GlycoMimetics Inc. (GLYC)
GlycoMimetics Statistics
Share Statistics
GlycoMimetics has 64.48M shares outstanding. The number of shares has increased by 0.05% in one year.
| Shares Outstanding | 64.48M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 57.07M |
| Failed to Deliver (FTD) Shares | 31.59K |
| FTD / Avg. Volume | 0.15% |
Short Selling Information
The latest short interest is 5.64M, so 8.74% of the outstanding shares have been sold short.
| Short Interest | 5.64M |
| Short % of Shares Out | 8.74% |
| Short % of Float | 9.88% |
| Short Ratio (days to cover) | 1.07 |
Valuation Ratios
The PE ratio is -4.05 and the forward PE ratio is -4.39.
| PE Ratio | -4.05 |
| Forward PE | -4.39 |
| PS Ratio | 14948.82 |
| Forward PS | 13.3 |
| PB Ratio | 3.89 |
| P/FCF Ratio | -4.28 |
| PEG Ratio | n/a |
Enterprise Valuation
GlycoMimetics Inc. has an Enterprise Value (EV) of 108.50M.
| EV / Earnings | -2.94 |
| EV / Sales | 10850.38 |
| EV / EBITDA | -2.77 |
| EV / EBIT | -2.76 |
| EV / FCF | -3.11 |
Financial Position
The company has a current ratio of 6.41, with a Debt / Equity ratio of 0.02.
| Current Ratio | 6.41 |
| Quick Ratio | 6.41 |
| Debt / Equity | 0.02 |
| Total Debt / Capitalization | 2.06 |
| Cash Flow / Debt | -43.15 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.96% and return on capital (ROIC) is -100.13%.
| Return on Equity (ROE) | -0.96% |
| Return on Assets (ROA) | -0.81% |
| Return on Capital (ROIC) | -100.13% |
| Revenue Per Employee | 285.71 |
| Profits Per Employee | -1.05M |
| Employee Count | 35 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | -637 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -91.28% in the last 52 weeks. The beta is 1.84, so GlycoMimetics 's price volatility has been higher than the market average.
| Beta | 1.84 |
| 52-Week Price Change | -91.28% |
| 50-Day Moving Average | 0.3 |
| 200-Day Moving Average | 0.47 |
| Relative Strength Index (RSI) | 48.4 |
| Average Volume (20 Days) | 20.56M |
Income Statement
In the last 12 months, GlycoMimetics had revenue of 10.00K and earned -36.90M in profits. Earnings per share was -0.58.
| Revenue | 10.00K |
| Gross Profit | 10.00K |
| Operating Income | -39.28M |
| Net Income | -36.90M |
| EBITDA | -39.12M |
| EBIT | -39.28M |
| Earnings Per Share (EPS) | -0.58 |
Balance Sheet
The company has 41.79M in cash and 808.40K in debt, giving a net cash position of 40.98M.
| Cash & Cash Equivalents | 41.79M |
| Total Debt | 808.40K |
| Net Cash | 40.98M |
| Retained Earnings | -456.49M |
| Total Assets | 15.70M |
| Working Capital | 11.32M |
Cash Flow
In the last 12 months, operating cash flow was -34.88M and capital expenditures -21.39K, giving a free cash flow of -34.90M.
| Operating Cash Flow | -34.88M |
| Capital Expenditures | -21.39K |
| Free Cash Flow | -34.90M |
| FCF Per Share | -0.55 |
Margins
Gross margin is 100%, with operating and profit margins of -392.75K% and -368.99K%.
| Gross Margin | 100% |
| Operating Margin | -392.75K% |
| Pretax Margin | -368.99K% |
| Profit Margin | -368.99K% |
| EBITDA Margin | -391.22K% |
| EBIT Margin | -392.75K% |
| FCF Margin | -349.01K% |
Dividends & Yields
GLYC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -223.08% |
| FCF Yield | -207.29% |
Analyst Forecast
The average price target for GLYC is $12, which is 4515.4% higher than the current price. The consensus rating is "Hold".
| Price Target | $12 |
| Price Target Difference | 4515.4% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
Scores
| Altman Z-Score | -48.06 |
| Piotroski F-Score | 2 |